Who Buys Flucloxacillin from India — 198 Importers Behind a $38.8M Market
India's flucloxacillin import market is served by 198 active buyers who collectively imported $38.8M across 1,146 shipments. MEDREICH PLC (UNITED KINGDOM) leads with a 24.3% market share, followed by MYLAN AUSTRALIA PTY LIMITED and BROWN AND BURK UK LIMITED. The top 5 buyers together control 55.6% of total import value, reflecting a moderately competitive buyer landscape.
Top Flucloxacillin Importers — Ranked by Import Value
MEDREICH PLC (UNITED KINGDOM) is the leading flucloxacillin importer from India, holding a 24.3% share of the $38.8M market across 1,146 shipments from 198 buyers. The top 5 buyers — MEDREICH PLC (UNITED KINGDOM), MYLAN AUSTRALIA PTY LIMITED (AUSTRALIA), BROWN AND BURK UK LIMITED (UNITED KINGDOM), MYLAN IRELAND LTD (NETHERLANDS), ORION CORPORATION (FINLAND) — collectively control 55.6% of total import value.
Top Flucloxacillin Buyers & Importers
Ranked by import value · 198 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | MEDREICH PLCUNITED KINGDOM FLUCLOXACILLIN 500MG CAPSULES BP 2X14SFLUCLOXACILLIN 500MG CAPSULES, HARDFLUCLOXACILLIN 500MG CAPSULES BP 2X14 | $9.4M | 5 | 24.3% |
| 2 | MYLAN AUSTRALIA PTY LIMITEDAUSTRALIA FLUCLOXACILLIN CAPSULES 500MG (STAPHLEXFLUCLOXACILLIN CAPSULES 500 MG (STAPHYLFLUCLOXACILLIN CAPSULES 500MG STAPHYLEX | $5.4M | 5 | 14.0% |
| 3 | BROWN AND BURK UK LIMITEDUNITED KINGDOM FLUCLOXACILLIN 500MG CAPSULES BP 2X14SFLUCLOXACILLIN 500MG CAPSULES, HARDFLUCLOXACILLIN 500MG CAPSULES BP 2X14 | $3.7M | 5 | 9.6% |
| 4 | MYLAN IRELAND LTDNETHERLANDS FLUCLOXACILLIN CAPSULES 500MG (STAPHLEXFLUCLOXACILLIN CAPSULES 500 MG (STAPHYLFLUCLOXACILLIN CAPSULES 500MG STAPHYLEX | $1.6M | 5 | 4.2% |
| 5 | ORION CORPORATIONFINLAND FLUCLOXACILLIN SODIUM TABLETS 1000MG(FLUFLUCLOXACILLIN SODIUM TABLETS 1000MG21'SFLUCLOXACILLIN SODIUM TABLETS 1000MG30'S | $1.4M | 5 | 3.5% |
| 6 | MYLAN B.VNETHERLANDS FLUCLOXACILLIN CAPSULES 500MG (STAPHLEXFLUCLOXACILLIN CAPSULES 500 MG (STAPHYLFLUCLOXACILLIN CAPSULES 500MG STAPHYLEX | $927.5K | 5 | 2.4% |
| 7 | ORION CORPORATION,FINLAND FLUCLOXACILLIN SODIUM TABLETS 1000MG(FLUFLUCLOXACILLIN SODIUM TABLETS 1000MG21'SFLUCLOXACILLIN SODIUM TABLETS 1000MG30'S | $865.3K | 5 | 2.2% |
| 8 | PLANET PHARMA SAFRANCE FLUKOCIN 250 (FLUCLOXACILLIN ORAL SOLUTIFLUKOCIN 500 (FLUCLOXACILLIN CAPSULES 50OXICLAR PFOS 250MG/5ML [FLUCLOXACILLIN O | $777.3K | 5 | 2.0% |
| 9 | MYLAN BVNETHERLANDS FLUCLOXACILLIN CAPSULES 500MG (STAPHLEXFLUCLOXACILLIN CAPSULES 500 MG (STAPHYLFLUCLOXACILLIN CAPSULES 500MG STAPHYLEX | $663.8K | 5 | 1.7% |
| 10 | OETHMAAN BIOSIMS PTY LTDSOUTH AFRICA MACROPEN 500 - TAX INV NO: 711204559 DT: 08.02.2024NOSMACROPEN 500 -TAX INVOICE NO: 711205473 DT: 29.03.2025 | $457.8K | 5 | 1.2% |
| 11 | NOUMED LIFESCIENCE LTDUNITED KINGDOM FLUCLOXACILLIN 500MG CAPSULES BP 2X14SFLUCLOXACILLIN 500MG CAPSULES, HARDFLUCLOXACILLIN 500MG CAPSULES BP 2X14 | $436.1K | 5 | 1.1% |
| 12 | MYLAN B V ALLOGA NETHERLANDS BVDE KEMPKENSNETHERLANDS FLUCLOXACILLIN CAPSULES 500MG (STAPHLEXFLUCLOXACILLIN CAPSULES 500 MG (STAPHYLFLUCLOXACILLIN CAPSULES 500MG STAPHYLEX | $427.8K | 5 | 1.1% |
| 13 | MYLAN B VNETHERLANDS FLUCLOXACILLIN CAPSULES 500MG (STAPHLEXFLUCLOXACILLIN CAPSULES 500 MG (STAPHYLFLUCLOXACILLIN CAPSULES 500MG STAPHYLEX | $287.7K | 5 | 0.7% |
| 14 | BROWN AND BURK LIMITEDUNITED KINGDOM FLUCLOXACILLIN 500MG CAPSULES BP 2X14SFLUCLOXACILLIN 500MG CAPSULES, HARDFLUCLOXACILLIN 500MG CAPSULES BP 2X14 | $280.4K | 5 | 0.7% |
| 15 | VIATRIS NEW ZEALANDNEW ZEALAND MACROPEN 500 - TAX INV NO: 711204559 DT: 08.02.2024NOSMACROPEN 500 -TAX INVOICE NO: 711205473 DT: 29.03.2025 | $278.0K | 5 | 0.7% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Flucloxacillin — and from which countries?
Flow of Flucloxacillin exports from India: each country's share and the named importers behind the numbers
Flucloxacillin — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1United Kingdom
United Kingdom emerges as the first largest importing country, achieving a total trade value of $14.1M through 235 shipments. This represents a market share of 36.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: United Kingdom has a diverse importer base, with their top importers including:
• MEDREICH PLC - $9.4M (66.6% of country's total business)
• BROWN AND BURK UK LIMITED - $3.7M (26.5% of country's total business)
• NOUMED LIFESCIENCE LTD - $436.1K (3.1% of country's total business)
• BROWN AND BURK LIMITED - $280.4K (2.0% of country's total business)
Key Insight: United Kingdom demonstrates strong market positioning with an average shipment value of $60.1K, indicating premium pricing strategy compared to the market average of $33.8K.
United Kingdom is a key market for Flucloxacillin imports, representing 36.4% of total trade value.
2Australia
Australia emerges as the second largest importing country, achieving a total trade value of $5.4M through 73 shipments. This represents a market share of 14.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Australia has a diverse importer base, with their top importers including:
• MYLAN AUSTRALIA PTY LIMITED - $5.4M (100.0% of country's total business)
Key Insight: Australia demonstrates strong market positioning with an average shipment value of $74.4K, indicating premium pricing strategy compared to the market average of $33.8K.
Australia is a key market for Flucloxacillin imports, representing 14.0% of total trade value.
3Netherlands
Netherlands emerges as the third largest importing country, achieving a total trade value of $3.9M through 84 shipments. This represents a market share of 10.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Netherlands has a diverse importer base, with their top importers including:
• MYLAN IRELAND LTD - $1.6M (41.2% of country's total business)
• MYLAN B.V - $927.5K (23.6% of country's total business)
• MYLAN BV - $663.8K (16.9% of country's total business)
• MYLAN B V ALLOGA NETHERLANDS BVDE KEMPKENS - $427.8K (10.9% of country's total business)
• MYLAN B V - $287.7K (7.3% of country's total business)
• Rest of Netherlands's importers - $0 (0.0% of country's total business)
Key Insight: Netherlands demonstrates strong market positioning with an average shipment value of $46.7K, indicating premium pricing strategy compared to the market average of $33.8K.
Netherlands is a key market for Flucloxacillin imports, representing 10.1% of total trade value.
4South Africa
South Africa emerges as the fourth largest importing country, achieving a total trade value of $3.5M through 10 shipments. This represents a market share of 9.1% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: South Africa has a diverse importer base, with their top importers including:
• OETHMAAN BIOSIMS PTY LTD - $457.8K (12.9% of country's total business)
Key Insight: South Africa demonstrates strong market positioning with an average shipment value of $354.9K, indicating premium pricing strategy compared to the market average of $33.8K.
South Africa is a key market for Flucloxacillin imports, representing 9.1% of total trade value.
5Finland
Finland emerges as the fifth largest importing country, achieving a total trade value of $2.3M through 63 shipments. This represents a market share of 6.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Finland has a diverse importer base, with their top importers including:
• ORION CORPORATION - $1.4M (58.6% of country's total business)
• ORION CORPORATION, - $865.3K (37.2% of country's total business)
Key Insight: Finland demonstrates strong market positioning with an average shipment value of $37.0K, indicating premium pricing strategy compared to the market average of $33.8K.
Finland is a key market for Flucloxacillin imports, representing 6.0% of total trade value.
Buyer Segment Analysis
TransData Nexus Flucloxacillin buyer market intelligence
1Buyer Segment Analysis
The importation of Flucloxacillin from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like MEDREICH PLC (United Kingdom) and MYLAN AUSTRALIA PTY LIMITED (Australia) function as intermediaries, procuring large quantities to supply to healthcare providers and pharmacies. Their purchasing patterns are characterized by bulk orders to maintain a steady supply chain.
- Contract Manufacturers: Companies such as MYLAN IRELAND LTD (Netherlands) and ORION CORPORATION (Finland) import Flucloxacillin to produce finished pharmaceutical products. Their procurement is driven by production schedules and market demand, leading to periodic, substantial orders.
- Re-exporters: Firms like PLANET PHARMA SA (France) may import Flucloxacillin for redistribution to other markets. Their buying behavior is influenced by global demand fluctuations and trade agreements, resulting in variable order sizes and frequencies.
Understanding these segments is crucial for tailoring supply strategies to meet the specific needs and purchasing patterns of each buyer type.
Country-Specific Import Regulations
TransData Nexus Flucloxacillin buyer market intelligence
1Country-Specific Import Regulations
The top five importing countries have distinct regulatory frameworks for Flucloxacillin:
- United Kingdom:
- Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
- Import Registration Process: Importers must hold a Wholesale Dealer's Licence and ensure that each batch is certified by a Qualified Person from an approved country.
- Estimated Timeline: The registration process typically takes several months, depending on the completeness of the application and compliance with regulatory standards.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30041090 are generally subject to a 0% import duty, but importers should verify current rates with HM Revenue & Customs.
- Australia:
- Regulatory Authority: Therapeutic Goods Administration (TGA).
- Import Registration Process: Medicines must be listed or registered in the Australian Register of Therapeutic Goods (ARTG). Importers need to provide evidence of compliance with TGA standards.
- Estimated Timeline: The registration process can range from several months to over a year, depending on the product's classification and the quality of the submitted data.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30041090 are typically duty-free, but importers should confirm with the Australian Border Force.
- Netherlands:
- Regulatory Authority: Medicines Evaluation Board (MEB).
- Import Registration Process: Medicines must be authorized by the MEB or the European Medicines Agency (EMA). Importers must comply with EU Good Manufacturing Practice (GMP) standards.
- Estimated Timeline: The registration process usually takes 7 to 12 months, depending on the type of application and completeness of the dossier.
- Import Tariff/Duty: As part of the EU, the Netherlands applies a 0% import duty on pharmaceutical products under HS Code 30041090.
- South Africa:
- Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
- Import Registration Process: Medicines must be registered with SAHPRA. Importers need to submit a comprehensive dossier demonstrating safety, efficacy, and quality.
- Estimated Timeline: The registration process can take 12 to 24 months, influenced by the complexity of the application and SAHPRA's review capacity.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30041090 are generally exempt from import duties, but importers should verify with the South African Revenue Service.
- Finland:
- Regulatory Authority: Finnish Medicines Agency (Fimea).
- Import Registration Process: Medicines must be authorized by Fimea or the EMA. Compliance with EU GMP standards is mandatory.
- Estimated Timeline: The registration process typically takes 7 to 12 months, depending on the application type and dossier quality.
- Import Tariff/Duty: As an EU member, Finland applies a 0% import duty on pharmaceutical products under HS Code 30041090.
Importers should consult the respective regulatory authorities for the most current information and guidance.
Demand Drivers & Market Opportunity
TransData Nexus Flucloxacillin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Flucloxacillin in importing countries is influenced by several factors:
- Disease Prevalence: Flucloxacillin is commonly used to treat infections caused by penicillinase-producing staphylococci. High prevalence of such bacterial infections in certain regions drives demand for this antibiotic.
- Government Healthcare Programs: Many countries have national health programs that ensure the availability of essential medicines, including antibiotics like Flucloxacillin. These programs often involve bulk procurement to supply public healthcare facilities.
- Universal Health Coverage Expansion: Efforts to expand universal health coverage increase access to essential medicines, leading to higher demand. Countries investing in healthcare infrastructure and coverage are likely to see a rise in Flucloxacillin consumption.
- WHO Essential Medicines List Procurement: Flucloxacillin's inclusion in the WHO Model List of Essential Medicines encourages its procurement by member states, ensuring its availability in public health systems.
- Tender-Based Purchasing: Many governments and large healthcare providers use tender systems to procure medicines. The competitive nature of tenders can influence the volume and frequency of Flucloxacillin imports.
With 198 buyers across 44 countries, the market for Flucloxacillin is diverse and influenced by regional health needs and policies. Monitoring these factors can help identify emerging opportunities and tailor supply strategies accordingly.
Common Questions — Flucloxacillin Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest flucloxacillin buyer importing from India?
Based on import volume and value, MEDREICH PLC (UNITED KINGDOM) leads with $9.4M in imports and a 24.3% market share — the highest of any single flucloxacillin importer. MYLAN AUSTRALIA PTY LIMITED (AUSTRALIA) and BROWN AND BURK UK LIMITED (UNITED KINGDOM) are the next largest buyers.
QHow many companies buy flucloxacillin from India?
There are 198 active flucloxacillin buyers importing from India, with a combined market of $38.8M across 1,146 shipments to 44 countries. The top 5 buyers hold 55.6% of total import value, while the remaining 193 buyers handle the other 44.4%.
QWhich countries import the most flucloxacillin from India?
The top importing countries for flucloxacillin from India are United Kingdom (36.4%), Australia (14.0%), Netherlands (10.1%), South Africa (9.1%), Finland (6.0%). These markets represent the largest demand centres for Indian pharmaceutical exports of flucloxacillin, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for flucloxacillin from India?
The average import transaction value for flucloxacillin from India is $33.8K, with an average unit price of $11.71 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Flucloxacillin buyer market intelligence
1Buyer Segment Analysis
The importation of Flucloxacillin from India involves various buyer segments, each with distinct purchasing behaviors:
- Distributors: Entities like MEDREICH PLC (United Kingdom) and MYLAN AUSTRALIA PTY LIMITED (Australia) function as intermediaries, procuring large quantities to supply to healthcare providers and pharmacies. Their purchasing patterns are characterized by bulk orders to maintain a steady supply chain.
- Contract Manufacturers: Companies such as MYLAN IRELAND LTD (Netherlands) and ORION CORPORATION (Finland) import Flucloxacillin to produce finished pharmaceutical products. Their procurement is driven by production schedules and market demand, leading to periodic, substantial orders.
- Re-exporters: Firms like PLANET PHARMA SA (France) may import Flucloxacillin for redistribution to other markets. Their buying behavior is influenced by global demand fluctuations and trade agreements, resulting in variable order sizes and frequencies.
Understanding these segments is crucial for tailoring supply strategies to meet the specific needs and purchasing patterns of each buyer type.
Country-Specific Import Regulations
TransData Nexus Flucloxacillin buyer market intelligence
1Country-Specific Import Regulations
The top five importing countries have distinct regulatory frameworks for Flucloxacillin:
- United Kingdom:
- Regulatory Authority: Medicines and Healthcare products Regulatory Agency (MHRA).
- Import Registration Process: Importers must hold a Wholesale Dealer's Licence and ensure that each batch is certified by a Qualified Person from an approved country.
- Estimated Timeline: The registration process typically takes several months, depending on the completeness of the application and compliance with regulatory standards.
- Import Tariff/Duty: Pharmaceutical products under HS Code 30041090 are generally subject to a 0% import duty, but importers should verify current rates with HM Revenue & Customs.
- Australia:
- Regulatory Authority: Therapeutic Goods Administration (TGA).
- Import Registration Process: Medicines must be listed or registered in the Australian Register of Therapeutic Goods (ARTG). Importers need to provide evidence of compliance with TGA standards.
- Estimated Timeline: The registration process can range from several months to over a year, depending on the product's classification and the quality of the submitted data.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30041090 are typically duty-free, but importers should confirm with the Australian Border Force.
- Netherlands:
- Regulatory Authority: Medicines Evaluation Board (MEB).
- Import Registration Process: Medicines must be authorized by the MEB or the European Medicines Agency (EMA). Importers must comply with EU Good Manufacturing Practice (GMP) standards.
- Estimated Timeline: The registration process usually takes 7 to 12 months, depending on the type of application and completeness of the dossier.
- Import Tariff/Duty: As part of the EU, the Netherlands applies a 0% import duty on pharmaceutical products under HS Code 30041090.
- South Africa:
- Regulatory Authority: South African Health Products Regulatory Authority (SAHPRA).
- Import Registration Process: Medicines must be registered with SAHPRA. Importers need to submit a comprehensive dossier demonstrating safety, efficacy, and quality.
- Estimated Timeline: The registration process can take 12 to 24 months, influenced by the complexity of the application and SAHPRA's review capacity.
- Import Tariff/Duty: Pharmaceuticals under HS Code 30041090 are generally exempt from import duties, but importers should verify with the South African Revenue Service.
- Finland:
- Regulatory Authority: Finnish Medicines Agency (Fimea).
- Import Registration Process: Medicines must be authorized by Fimea or the EMA. Compliance with EU GMP standards is mandatory.
- Estimated Timeline: The registration process typically takes 7 to 12 months, depending on the application type and dossier quality.
- Import Tariff/Duty: As an EU member, Finland applies a 0% import duty on pharmaceutical products under HS Code 30041090.
Importers should consult the respective regulatory authorities for the most current information and guidance.
Demand Drivers & Market Opportunity
TransData Nexus Flucloxacillin buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Flucloxacillin in importing countries is influenced by several factors:
- Disease Prevalence: Flucloxacillin is commonly used to treat infections caused by penicillinase-producing staphylococci. High prevalence of such bacterial infections in certain regions drives demand for this antibiotic.
- Government Healthcare Programs: Many countries have national health programs that ensure the availability of essential medicines, including antibiotics like Flucloxacillin. These programs often involve bulk procurement to supply public healthcare facilities.
- Universal Health Coverage Expansion: Efforts to expand universal health coverage increase access to essential medicines, leading to higher demand. Countries investing in healthcare infrastructure and coverage are likely to see a rise in Flucloxacillin consumption.
- WHO Essential Medicines List Procurement: Flucloxacillin's inclusion in the WHO Model List of Essential Medicines encourages its procurement by member states, ensuring its availability in public health systems.
- Tender-Based Purchasing: Many governments and large healthcare providers use tender systems to procure medicines. The competitive nature of tenders can influence the volume and frequency of Flucloxacillin imports.
With 198 buyers across 44 countries, the market for Flucloxacillin is diverse and influenced by regional health needs and policies. Monitoring these factors can help identify emerging opportunities and tailor supply strategies accordingly.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 198 global importers of Flucloxacillin identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 1,146 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 44 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
1,146 Verified Shipments
198 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists